68 results
SC 13E3/A
EX-99
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
is subject to a condition that a majority of Satsuma’s outstanding shares of common stock is tendered or owned by the Company, the Offeror or any
8-K
EX-3.2
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Termination of a Material Definitive Agreement
9:13am
of incorporation or these bylaws, at each meeting of stockholders the presence in person or by proxy of the holders of shares of stock having a majority … to constitute a quorum. Where a separate vote by a class or series or classes or series is required, a majority of the outstanding shares of such class
SC 14D9/A
STSA
Satsuma Pharmaceuticals Inc
24 May 23
Tender offer solicitation (amended)
9:40pm
for the approval of a majority of the Unaffiliated Stockholders as the Offer is not structured in such a manner that such approval is required
SC 14D9
STSA
Satsuma Pharmaceuticals Inc
5 May 23
Tender offer solicitation
8:17am
with any Shares owned by the Purchaser Parties, represent at least a majority of the aggregate number of Shares outstanding immediately after … Standard Time) on July 15, 2023 (the “Termination Date”) (iv) the mutual written consent of Parent, Purchaser and stockholders holding a majority
8-K
EX-2.2
6cg498ibfhmp t3dal
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-99.1
zxd goisjuk8tc4ik
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-2.1
f16cqd2hj
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
p43pj1kx9 rn9nun8tu
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
SC TO-C
EX-99.2
szsvo0t6hzl jb07
17 Apr 23
Information about tender offer
6:08am
8-K
EX-99.2
2q5rdi8l70o28sfbu
20 Dec 22
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
4:19pm
424B5
dwvnrm gqpd
3 Nov 22
Prospectus supplement for primary offering
4:42pm